Original document(10 pages)  中文版
    The present invention relates to entecavir effervescent tablet as one hepatitis B treating medicine and its preparation process, and aims at providing one kind of entecavir effervescent tablet preparation with the features of accurate dosage, stable quality, easy production and convenient carrying like other common solid preparation, and the features of easy swallow, high bioavailability, less stimulation on gastrointestinal tract, etc like orally taken liquid preparation. The entecavir effervescent tablet is prepared with entecavir as main material and proper amount of medicine supplementary material and through a conventional technological process.
Application Number
申请号
200610152511 Application Date
申请日
2006.09.28
Title 名称 Entecavir effervescent tablet and its prepn process
Publication Number
公开号
1931144 Publication Date
公开日
2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/46;A61K31/513;A61P1/16;A61P31/12
Applicant(s) Name
申请人
Henan Furen Pharmaceutical Industry Group Corp., Ltd.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
Prepn process of malaytea scurfpea injection
Traditional Chinese medicine preparation for treating leukoderma, psoriasis and its preparation method
Orally administered medicinal composition for treating diabetes
An anti-tumor antibiotic and anti-inflammation pharmaceutical composition and preparation method thereof
A pharmaceutical composition for preventing and treating coronary heart disease and angina pectoris and method for preparing same
A pharmaceutical composition for preventing and treating angina pectoris and cardiac infarction and method for preparing same
Orally taken liquid medicine composition containing strontium
Diterpene compound and derivative in kaurene class of new disymmetry
Traditional Chinese medicine mixture for treating AIDS stomatocace and recurrent stomatocace
Bamboo floor producing technology
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.